Clostridioides difficile Infection Is Associated with Adverse Outcomes among Hospitalized Pediatric Patients with Acute Pancreatitis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Studies in adults have shown an increasing incidence of Clostridioides difficile infection (CDI) in patients hospitalized with acute pancreatitis (AP). There is lack of epidemiological data on CDI and its impact on hospitalized pediatric patients with AP. Methods: We analyzed the National Inpatient Sample and Kids' Inpatient Database between the years 2003 and 2016 and included all patients (age <21 years) with a primary diagnosis of AP using specific International Classification of Diseases codes. We compared clinical outcomes between children with CDI and those without CDI. Our primary outcome was severe AP and secondary outcomes included length of stay and hospital charges. Results: A total of 123,240 hospitalizations related to AP were analyzed and CDI was noted in 0.6% of the hospital. The prevalence rate of CDI doubled from 0.4% (2003) to 0.8% (2016), p=0.03. AP patients with CDI had increased comorbidities, and also underwent more invasive surgical procedures, p<0.05. AP patients with CDI had a higher in-hospital mortality rate and increased prevalence of severe AP, p<0.001. Multivariate regression models showed that CDI was associated with 2.4 times (confidence interval [CI]: 1.91 to 3.01, p<0.001) increased odds of severe AP. CDI patients had 7.24 (CI: 6.81 to 7.67, p<0.001) additional hospital days while incurring $59,032 (CI: 54,050 to 64,014, p<0.001) additional hospitalization charges. Conclusion: CDI in pediatric patients with AP is associated with adverse clinical outcomes and increased healthcare resource utilization. Further studies are needed to elucidate this association to prevent the development of CDI and to improve outcomes.
Abstract
Purpose: Studies in adults have shown an increasing incidence of Clostridioides difficile infection (CDI) in patients hospitalized with acute pancreatitis (AP). There is lack of epidemiological data on CDI and its impact on hospitalized pediatric patients with AP. Methods: We analyzed the National Inpatient Sample and Kids' Inpatient Database between the years 2003 and 2016 and included all patients (age <21 years) with a primary diagnosis of AP using specific International Classification of Diseases codes. We compared clinical outcomes between children with CDI and those without CDI. Our primary outcome was severe AP and secondary outcomes included length of stay and hospital charges. Results: A total of 123,240 hospitalizations related to AP were analyzed and CDI was noted in 0.6% of the hospital. The prevalence rate of CDI doubled from 0.4% (2003) to 0.8% (2016), p=0.03. AP patients with CDI had increased comorbidities, and also underwent more invasive surgical procedures, p<0.05. AP patients with CDI had a higher in-hospital mortality rate and increased prevalence of severe AP, p<0.001. Multivariate regression models showed that CDI was associated with 2.4 times (confidence interval [CI]: 1.91 to 3.01, p<0.001) increased odds of severe AP. CDI patients had 7.24 (CI: 6.81 to 7.67, p<0.001) additional hospital days while incurring $59,032 (CI: 54,050 to 64,014, p<0.001) additional hospitalization charges. Conclusion: CDI in pediatric patients with AP is associated with adverse clinical outcomes and increased healthcare resource utilization. Further studies are needed to elucidate this association to prevent the development of CDI and to improve outcomes.
참고문헌 (20)
- Peery AF, "Burden of gastrointestinal disease in the United States : 2012 update", Gastroenterology, 143, pp.1179~1187 (2012)[DOI]
- Peery AF, "Burden of gastrointestinal, liver, and pancreatic diseases in the United States", Gastroenterology, 149, pp.1731~1741 (2015)[DOI]
- Deshpande A, "Clostridium difficile infection in the hospitalized pediatric population : increasing trend in disease incidence", Pediatr Infect Dis J, 32, pp.1138~1140 (2013)
- Nylund CM, "Clostridium difficile infection in hospitalized children in the United States", Arch Pediatr Adolesc Med, 165, pp.451~457 (2011)
- Vaishnavi C, "Pancreatic disease patients are at higher risk for Clostridium difficile infection compared to those with other co-morbidities", Gut Pathog, 11, pp.17~ (2019)
- Trikudanathan G, "Impact of Clostridium difficile infection in patients hospitalized with acute pancreatitis-a population based cohort study", Pancreatology, 17, pp.201~202 (2017)
- Garg S, "Clostridium difficile infection is associated with poor outcomes in acute pancreatitis : results from the Nationwide Inpatient Sample", Am J Gastroenterol, 111, pp.S99~ (2016)
- Allegretti JR, "Risk factors for Clostridium difficile infections in patients hospitalized with acute pancreatitis", Am J Gastroenterol, 110, pp.S21~ (2015)
- Maatman TK, "The morbidity of C. difficile in necrotizing pancreatitis", Am J Surg, 219, pp.509~512 (2020)
- Working Group IAP, "APA Acute Pancreatitis Guidelines", IAP, Pancreatology, pp.2013, 13(4)[DOI]
- Abu-El-Haija M, "Management of acute pancreatitis in the pediatric population : a clinical report from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas Committee", J Pediatr Gastroenterol Nutr, 66, pp.159~176 (2018)
- Párniczky A, "Antibiotic therapy in acute pancreatitis : from global overuse to evidence based recommendations", Pancreatology, 19, pp.488~499 (2019)
- Pant C, "Epidemiology of acute pancreatitis in hospitalized children in the United States from 2000-2009", PLoS One, 9, pp.e95552~ (2014)
- Abu-El-Haija M, "Acute pancreatitis admission trends : a national estimate through the Kids’ Inpatient Database", J Pediatr, 194, pp.147~151 (2018)[DOI]
- Thavamani A, "The increasing prevalence and adverse impact of morbid obesity in paediatric acute pancreatitis", Pediatr Obes, 15, pp.e12643~ (2020)
- Abu-El-Haija M, "Classification of acute pancreatitis in the pediatric population : clinical report from the NASPGHAN pancreas committee", J Pediatr Gastroenterol Nutr, 64, pp.984~990 (2017)
- Wu LM, "Meta-analysis of gut barrier dysfunction in patients with acute pancreatitis", Br J Surg, 101, pp.1644~1656 (2014)
- Capurso G, "Role of the gut barrier in acute pancreatitis", J Clin Gastroenterol, 46, pp.S46~51 (2012)
- Baltatzis M, "Antibiotic use in acute pancreatitis : an audit of current practice in a tertiary centre", Pancreatology, 16, pp.946~951 (2016)
- Atassi H, "Su1461 adverse healthcare resource outcomes in patients with acute pancreatitis who develop Clostridium difficile infection during hospitalization", Gastroenterology (2020)